NCT04905056

A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Shanghai Zhongshan Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

A prospective, two-center, single arm phase II clinical study to evaluate safety and effectiveness of ablation therapy in the treatment of lung cancer presenting as ground-glass nodules

Conditions

• Progression

Interventions

Type	Name	Description
OTHER	Ablation therapy	Ablation therapy in the treatment of lung cancer presenting as ground-glass nodules

Timeline

• Start date: 2021-01-01
• Primary completion: 2025-12-31
• Completion: 2028-12-31
• First posted: 2021-05-27
• Last updated: 2021-05-27

Locations

1 site across 1 country: China